Search Within

Shanu Modi

  1. "2021"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (3)
  3. Review (3)
  4. Editorial (1)
Groups
  1. Breast Medicine Service (19)
  2. Department of Medicine (19)
  3. Solid Tumor Oncology Division (19)
  4. GSK Faculty (6)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  6. Human Oncology and Pathogenesis Program (4)

More Groups

People
  1. Joshua Drago (3)
  2. Sarat Chandarlapaty (3)
  3. Charles Rudin (2)
  4. Chau Dang (2)
  5. Elizabeth Comen (2)
  6. Emanuela Ferraro (2)

More People

Years
  1. 2021 (19)
Publications
  1. Cancer Research (5)
  2. Annals of Oncology (3)
  3. Journal of Clinical Oncology (3)
  4. Clinical Cancer Research (2)
  5. Breast Cancer Research (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (3)
  3. Oxford University Press (3)
  4. American Medical Association (1)
  5. Biomed Central Ltd (1)
  6. Elsevier Inc. (1)

More Publishers

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interstitial lung disease induced by anti-ERBB2 antibody-drug conjugates: A review
    Review

    Tarantino, P.; Modi, S.; Tolaney, S. M.; Cortes, J.; Hamilton, E. P.; Kim, S. B.; Toi, M.; Andrè, F.; Curigliano, G.
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (T-DXd) in patients with HER2+ metastatic breast cancer with brain metastases: A subgroup analysis of the DESTINY-Breast01 trial
    Meeting Abstract

    Jerusalem, G. H. M.; Park, Y. H.; Yamashita, T.; Hurvitz, S. A.; Modi, S.; Andre, F.; Krop, I. E.; Gonzalez, X.; Hall, P. S.; You, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (T-DXd) in patients with human epidermal growth factor receptor 2 (HER2)-expressing salivary duct carcinoma: Subgroup analysis of two phase 1 studies
    Meeting Abstract

    Bando, H.; Kinoshita, I.; Modi, S.; Tsurutani, J.; Bang, Y. J.; Iwata, H.; Sato, Y.; Nakatani, S.; Lee, C. C.; Sugihara, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Change in HER2 status after neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in patients with HER2-positive early-stage breast cancer
    Meeting Abstract

    Ferraro, E.; Razavi, P.; Chandarlapaty, S.; Modi, S.; Wen, H. Y.; Brogi, E.; Norton, L.; Robson, M. E.; Dang, C. T.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan (T-DXd) in patients with HER2-positive metastatic breast cancer (MBC): Updated survival results from a phase II trial (DESTINY-Breast01)
    Meeting Abstract

    Saura Manich, C.; Modi, S.; Krop, I.; Park, Y. H.; Kim, S. B.; Tamura, K.; André, F.; Iwata, H.; Ito, Y.; Tsurutani, J.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer
    Meeting Abstract

    Tsai, M.; Han, H. S.; Montero, A. J.; Tkaczuk, K. H.; Assad, H.; Pusztai, L.; Hurvitz, S. A.; Wilks, S. T.; Specht, J. M.; Nanda, R.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in previously treated HER2-positive metastatic breast cancer: Plain language summary of the DESTINY-Breast01 study
    Editorial

    Modi, S.
    Future Oncology (2021)

    Fulltext@MSK | Save
  • Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies
    Meeting Abstract

    Powell, C. A.; Modi, S.; Iwata, H.; Takahashi, S.; Smit, E. F.; Siena, S.; Chang, D. Y.; Fuchs, C. S.; Nie, K.; Qin, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save